Back to results
US 10,588,886 B2Granted
Methods for treating neutropenia
AssigneeEnzychem Lifesciences Corporation
InventorsKi-Young Sohn, Jae Wha Kim
Life of this patent
Estimating the term…
Abstract
The disclosure provides methods for treating, controlling or mitigating leukopenia (e.g. neutropenia) and/or thrombocytopenia, for example in the context of cancer chemotherapy, comprising administration of a monoacetyl-diacyl-glycerol compound, as well as compositions useful therefor.
Claims22
A method for treating chemotherapy-induced neutropenia, comprising administering to a human in need thereof, an effective amount of a compound of Formula 2:
- wherein an Absolute Neutrophil Count in the human does not decrease to less than 500/μl.
The method of 5, wherein the chemotherapeutic agent is lenalidomide.
Dependencies are inferred from the claim text.